Stem Point Capital LP Portfolio Holdings
Stem Point Capital LP
- $401 Billion
- Q4 2024
Stem Point Capital LP has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $401 Billion distributed in 58 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Syndax Pharmaceuticals Inc with a value of $38B, Roivant Sciences Ltd. with a value of $32.1B, Immunovant, Inc. with a value of $27.7B, Merus N.V. with a value of $25.9B, and Crinetics Pharmaceuticals, Inc. with a value of $16.2B.
Examining the 13F form we can see an increase of $66.6B in the current position value, from $334B to 401B.
Stem Point Capital LP is based out at New York, NY
Below you can find more details about Stem Point Capital LP portfolio as well as his latest detailed transactions.